Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/9485094

Download in:

View as

General Info

PMID
9485094